Ok‐Cheol Jeon
Deargen (South Korea)(KR)
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, Angiogenesis and VEGF in Cancer, Drug Transport and Resistance Mechanisms, Proteoglycans and glycosaminoglycans research, Atrial Fibrillation Management and Outcomes
Most-Cited Works
- → Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells(2015)80 cited
- → Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation(2016)71 cited
- → Polyproline‐type helical‐structured low‐molecular weight heparin (LMWH)‐taurocholate conjugate as a new angiogenesis inhibitor(2008)67 cited
- → Self‐Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase‐Cleavable Linker(2018)37 cited
- → Enhanced Oral Absorption of Ibandronate via Complex Formation with Bile Acid Derivative(2012)17 cited
- → Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer(2018)14 cited
- → Radiotherapy‐assisted tumor selective metronomic oral chemotherapy(2017)9 cited
- → Safety studies on intravenous infusion of a potent angiogenesis inhibitor: taurocholate-conjugated low molecular weight heparin derivative LHT7 in preclinical models(2015)8 cited
- → Preclinical safety evaluation of low molecular weight heparin–deoxycholate conjugates as an oral anticoagulant(2015)7 cited
- → Preparation of Oxaliplatin-Deoxycholic Acid Derivative Nanocomplexes and In Vivo Evaluation of Their Oral Absorption and Tumor Growth Suppression(2015)7 cited